
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $23.3M | -- | -- | -$0.31 | -- |
08/06/2025 | Q2 | $28.1M | -- | -- | $0.38 | -- |
05/13/2025 | Q1 | $9.6M | $13.2M | -$0.65 | -$0.69 | $0.04 |
03/20/2025 | Q4 | $34.2M | $17.7M | -$0.25 | -$0.59 | $0.34 |
11/05/2024 | Q3 | $87.6M | $110.7M | $0.90 | $0.60 | $0.30 |
08/06/2024 | Q2 | $17.9M | $10.8M | -$0.89 | -$0.59 | -$0.30 |
05/09/2024 | Q1 | $14.9M | $9.1M | -$0.84 | -$0.64 | -$0.20 |
03/07/2024 | Q4 | $32.6M | $9.2M | -$0.75 | -$0.17 | -$0.58 |
11/06/2023 | Q3 | -- | -- | $0.28 | -$0.35 | $0.63 |
08/09/2023 | Q2 | -- | -- | $0.92 | -$0.50 | $1.42 |
05/09/2023 | Q1 | -- | -- | -$0.61 | $0.35 | -$0.96 |
03/15/2023 | Q4 | -- | -- | $0.21 | $0.01 | $0.20 |
11/03/2022 | Q3 | -- | -- | -$0.40 | -$0.36 | -$0.04 |
08/08/2022 | Q2 | -- | -- | -$0.67 | -$0.97 | $0.30 |
05/03/2022 | Q1 | -- | -- | -$1.08 | -$0.85 | -$0.23 |
02/24/2022 | Q4 | -- | -- | -$0.95 | -$0.81 | -$0.14 |
11/02/2021 | Q3 | -- | -- | -$0.86 | -$0.72 | -$0.15 |
07/29/2021 | Q2 | -- | -- | -$0.66 | -$0.41 | -$0.25 |
04/29/2021 | Q1 | -- | -- | -$0.90 | -$0.63 | -$0.27 |
02/25/2021 | Q4 | -- | -- | $0.02 | -$0.60 | $0.62 |
11/04/2020 | Q3 | -- | -- | -$0.66 | -$1.02 | $0.36 |
07/30/2020 | Q2 | -- | -- | -$0.94 | -$1.00 | $0.06 |
05/05/2020 | Q1 | -- | -- | -$0.91 | -$1.04 | $0.13 |
02/25/2020 | Q4 | -- | -- | -$0.62 | -$1.16 | $0.54 |
11/06/2019 | Q3 | -- | -- | -$0.91 | -$1.11 | $0.20 |
07/31/2019 | Q2 | -- | -- | -$0.65 | -$1.07 | $0.42 |
05/01/2019 | Q1 | -- | -- | -$0.99 | -$0.87 | -$0.12 |
02/26/2019 | Q4 | -- | -- | -$1.06 | -$0.96 | -$0.10 |
11/07/2018 | Q3 | -- | -- | -$0.81 | -$1.30 | $0.49 |
08/07/2018 | Q2 | -- | -- | -$1.03 | -- | -- |
05/07/2018 | Q1 | -- | -- | -$1.34 | -- | -- |
02/27/2018 | Q4 | -- | -- | $2.96 | -- | -- |
11/08/2017 | Q3 | -- | -- | -$1.28 | -- | -- |
08/02/2017 | Q2 | -- | -- | -$1.14 | -- | -- |
05/03/2017 | Q1 | -- | -- | -$1.08 | -- | -- |
02/28/2017 | Q4 | -- | -- | -$1.00 | -- | -- |
11/02/2016 | Q3 | -- | -- | -$0.97 | -- | -- |
08/03/2016 | Q2 | -- | -- | $1.12 | -- | -- |
05/04/2016 | Q1 | -- | -- | -$0.88 | -- | -- |
02/29/2016 | Q4 | -- | -- | -$0.90 | -- | -- |
11/04/2015 | Q3 | -- | -- | -$0.46 | -- | -- |
Macrogenics reported $13.2M worth of top line sales in its most recent quarter.
Macrogenics announced earnings per share of -$0.65 which represents a beat of analyst forecast a -$0.69 per share.
Macrogenics reported $7.8M that represents $0.12 per share over the last quarter.
Macrogenics's earnings are forecast to decrease from -$1.07 per share to -$1.42 per share next year representing a decrease of -41.12%.
Macrogenics's next earnings date is August 6, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.